Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Kimbel KJ, Kullgren JT, Meenan RT, Vernon SW Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial 2019 Jul 3;2(7):e196570. doi: 10.1001/jamanetworkopen.2019.6570. Epub 2019-07-03. PubMed
Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019-05-17. PubMed
Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN, PROSPR consortium Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005. PubMed
Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J Risk of second breast cancer events with chronic opioid use in breast cancer survivors 2019 May;28(5):740-753. doi: 10.1002/pds.4779. Epub 2019-04-03. PubMed
Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients 2019 May;28(5):996-999. doi: 10.1158/1055-9965.EPI-18-1324. Epub 2019-04-09. PubMed
Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J Use of antidepressants after colon cancer diagnosis and risk of recurrence 2019 Apr;28(4):750-758. doi: 10.1002/pon.5015. Epub 2019-02-14. PubMed
Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ Time to fecal immunochemical test completion for colorectal cancer screening 2019 Apr;25(4):174-180. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.